According to our (Global Info Research) latest study, the global Ketoconazole Cream market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Ketoconazole cream is a broad-spectrum antifungal drug with ketoconazole as its main ingredient. It treats skin problems caused by fungal infections such as tinea manuum, tinea pedis, tinea corporis, tinea cruris, tinea versicolor, and cutaneous candidiasis by inhibiting fungal growth. It can effectively kill a variety of skin fungi and yeasts. However, care should be taken to avoid contact with the eyes when using it. It is contraindicated for those who are allergic to this product and should not be used on large areas.
In 2024, the global production of ketoconazole cream was 92.71 million units, with an average price of US$0.7 per unit.Gross profit margins typically range from 40% to 60%.
The upstream supply chain of ketoconazole cream mainly consists of chemical raw material companies and excipient suppliers, including ketoconazole raw materials, cream base, stabilizers, and packaging materials. The upstream sector is characterized by large-scale and mature operations, with cost fluctuations influenced by raw material chemical prices and regulatory compliance costs, but overall supply is sufficient. The downstream sector is more crucial, primarily encompassing hospitals and retail pharmacies, as well as online drug retail platforms. Prescription demand is influenced by hospital antifungal medication guidelines, medical insurance catalogs, and competition from clinical alternatives, while OTC demand relies on consumer self-purchase demand, brand awareness, and channel coverage. Fungal skin diseases have a high prevalence and recurrence rate globally and in China, ensuring stable downstream demand. Branded drugs and cost-effective generic drugs coexist, with terminal competition focusing on dosage form improvements, reduced skin irritation, and increased accessibility.
Future development trends mainly include increased consumer awareness of self-skin care, continued expansion of OTC channels, and a trend towards more convenient and gentler dermatological medications. New channels, represented by online retail, will continue to improve product accessibility and drive product structure evolution towards branding and differentiation. The driving factors stem from the sustained demand resulting from the stable prevalence and high recurrence rate of fungal infections, as well as the preference for high-quality products following the increasingly standardized regulation of topical dermatological medications. Meanwhile, improvements by companies in cream bases, absorption rates, and skin barrier friendliness are also enhancing product competitiveness. The main obstacles include the strong availability of substitutes for topical antifungal drugs, such as terbinafine and clotrimazole; furthermore, the perception that safety controversies surrounding oral ketoconazole formulations extend to topical formulations in some countries, requiring brands to be more cautious in their advertising. Continued price competition at the retail level may also compress profit margins for branded companies.
This report is a detailed and comprehensive analysis for global Ketoconazole Cream market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ketoconazole Cream market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ketoconazole Cream market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ketoconazole Cream market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ketoconazole Cream market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ketoconazole Cream
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ketoconazole Cream market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Bayer, Almirall, Teva Pharmaceutical, Viatris, Taro Pharmaceutical Industries, Sandoz, Sun Pharmaceutical, Cipla, Dr. Reddy's, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ketoconazole Cream market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Single-Ingredient Preparations
Combination Preparations
Market segment by Concentration
2%
1%
Others
Market segment by Specifications
7g
10g
15g
25g
30g
Others
Market segment by Sales Channels
Online Sales
Offline Sales
Market segment by Application
Tinea Corporis
Tinea Cruris
Tinea Manuum
Tinea Pedis
Tinea Versicolor
Cutaneous Candidiasis
Malassezia Folliculitis
Others
Major players covered
Johnson & Johnson
Bayer
Almirall
Teva Pharmaceutical
Viatris
Taro Pharmaceutical Industries
Sandoz
Sun Pharmaceutical
Cipla
Dr. Reddy's
Glenmark Pharmaceuticals
Zydus Lifesciences
Hikma
AdvaCare Pharma
Leeford
Shanghai Baolong Pharmaceutical
Fujian Pacific Pharmaceutical
Hubei Heng'an Fulin Pharmaceutical
Hainan Haiyao
Chengdu Diao Pharmaceutical Group
Shanghai Pharmaceuticals Holding
Henan Lingrui Pharmaceutical
Zhejiang Dingtai Pharmaceutical
Zennova Pharma Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ketoconazole Cream product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ketoconazole Cream, with price, sales quantity, revenue, and global market share of Ketoconazole Cream from 2021 to 2026.
Chapter 3, the Ketoconazole Cream competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ketoconazole Cream breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ketoconazole Cream market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ketoconazole Cream.
Chapter 14 and 15, to describe Ketoconazole Cream sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Ketoconazole Cream. Industry analysis & Market Report on Ketoconazole Cream is a syndicated market report, published as Global Ketoconazole Cream Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Ketoconazole Cream market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.